A Putative Structural Mechanism Underlying the Antithetic Effect Of
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Neural Map Formation in the Mouse Olfactory System
Cell. Mol. Life Sci. (2014) 71:3049–3057 DOI 10.1007/s00018-014-1597-0 Cellular and Molecular Life Sciences REVIEW Neural map formation in the mouse olfactory system Haruki Takeuchi · Hitoshi Sakano Received: 25 November 2013 / Revised: 26 February 2014 / Accepted: 27 February 2014 / Published online: 18 March 2014 © The Author(s) 2014. This article is published with open access at Springerlink.com Abstract In the mouse olfactory system, odorants are Introduction detected by ~1,000 different odorant receptors (ORs) pro- duced by olfactory sensory neurons (OSNs). Each OSN In the mouse, various odorants are detected with approxi- expresses only one functional OR species, which is referred mately 1,000 different odorant receptors (ORs) expressed to as the “one neuron–one receptor” rule. Furthermore, OSN in the olfactory sensory neurons (OSNs) [1]. Each OSN in axons bearing the same OR converge to a specific projection the olfactory epithelium (OE) expresses only one functional site in the olfactory bulb (OB) forming a glomerular struc- OR gene in a mono-allelic manner [2]. Furthermore, OSNs ture, i.e., the “one glomerulus–one receptor” rule. Based on expressing the same OR converge their axons to a spe- these basic rules, binding signals of odorants detected by cific pair of glomeruli at stereotyped locations in the olfac- OSNs are converted to topographic information of activated tory bulb (OB) (Fig. 1a, b) [3]. Thus, the odor information glomeruli in the OB. During development, the glomerular detected in the OE is topographically represented as the pat- map is formed by the combination of two genetically pro- tern of activated glomeruli in the OB (Fig. -
Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Lysophosphatidic Acid Signaling in the Nervous System
Neuron Review Lysophosphatidic Acid Signaling in the Nervous System Yun C. Yung,1,3 Nicole C. Stoddard,1,2,3 Hope Mirendil,1 and Jerold Chun1,* 1Molecular and Cellular Neuroscience Department, Dorris Neuroscience Center, The Scripps Research Institute, La Jolla, CA 92037, USA 2Biomedical Sciences Graduate Program, University of California, San Diego School of Medicine, La Jolla, CA 92037, USA 3Co-first author *Correspondence: [email protected] http://dx.doi.org/10.1016/j.neuron.2015.01.009 The brain is composed of many lipids with varied forms that serve not only as structural components but also as essential signaling molecules. Lysophosphatidic acid (LPA) is an important bioactive lipid species that is part of the lysophospholipid (LP) family. LPA is primarily derived from membrane phospholipids and signals through six cognate G protein-coupled receptors (GPCRs), LPA1-6. These receptors are expressed on most cell types within central and peripheral nervous tissues and have been functionally linked to many neural pro- cesses and pathways. This Review covers a current understanding of LPA signaling in the nervous system, with particular focus on the relevance of LPA to both physiological and diseased states. Introduction LPA synthesis/degradative enzymes (reviewed in Sigal et al., The human brain is composed of approximately 60%–70% lipids 2005; Brindley and Pilquil, 2009; Perrakis and Moolenaar, by dry weight (Svennerholm et al., 1994). These lipids can be 2014). In view of the broad neurobiological influences of LPA divided into two major pools, structural and signaling, which signaling, its dysregulation may lead to diverse neuropathologies include well-known families such as cholesterol, fatty acids, ei- (Bandoh et al., 2000; Houben and Moolenaar, 2011; Yung et al., cosanoids, endocannabinoids, and prostaglandins (Figure 1). -
Reduced Expression of Semaphorin 4D and Plexin-B in Breast Cancer Is Associated with Poorer Prognosis and the Potential Linkage with Oestrogen Receptor
ONCOLOGY REPORTS 34: 1049-1057, 2015 Reduced expression of semaphorin 4D and plexin-B in breast cancer is associated with poorer prognosis and the potential linkage with oestrogen receptor MUHAMMAD FARAZ ARSHAD MALIK1,2, LIN YE1 and WEN G. JIANG1 1Metastasis and Angiogenesis Research Group, Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff CF14 4XN, UK; 2Department of Biosciences, COMSATS Institute of Information Technology, Islamabad 45550, Pakistan Received February 4, 2015; Accepted March 30, 2015 DOI: 10.3892/or.2015.4015 Abstract. Involvement of semaphorin 4D (Sema4D) and Introduction the receptor proteins of the plexins B family (plexin-B1, -B2 and -B3) in solid tumours suggests they play a role in Breast cancer is a heterogeneous disease influenced by genetic breast cancer. In the present study, the expression of Sema4D and environmental factors (1). Tumour metastasis is regulated and plexin-Bs was examined in a breast cancer cohort. by a set of non-randomized events, starting from loss of cancer The expression of Sema4D and plexin-Bs was examined in cells adhesion at the primary site, local invasion, intravasa- 147 tumours together with 22 normal mammary tissues using tion, survival in circulation, extravasation and colonisation at quantitative PCR along with clinicopathological patient data, distant sites. The nervous and vascular system share several as well as in MCF-7 and MDA-MB-231 cell lines treated anatomical and developmental similarities as these systems are with selective oestrogen receptor modulators (SERMs). The combined in neurovascular bundles and in peripheral tissues. expression of Sema4D, plexin-B1 and -B2 was markedly Notably, these shared developmental links also assist scientists reduced in tumours with local recurrence, compared to the to speculate the involvement of certain molecules controlling patients that remained disease-free. -
Figure S1. Representative Report Generated by the Ion Torrent System Server for Each of the KCC71 Panel Analysis and Pcafusion Analysis
Figure S1. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. A Figure S1. Continued. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. B Figure S2. Comparative analysis of the variant frequency found by the KCC71 panel and calculated from publicly available cBioPortal datasets. For each of the 71 genes in the KCC71 panel, the frequency of variants was calculated as the variant number found in the examined cases. Datasets marked with different colors and sample numbers of prostate cancer are presented in the upper right. *Significantly high in the present study. Figure S3. Seven subnetworks extracted from each of seven public prostate cancer gene networks in TCNG (Table SVI). Blue dots represent genes that include initial seed genes (parent nodes), and parent‑child and child‑grandchild genes in the network. Graphical representation of node‑to‑node associations and subnetwork structures that differed among and were unique to each of the seven subnetworks. TCNG, The Cancer Network Galaxy. Figure S4. REVIGO tree map showing the predicted biological processes of prostate cancer in the Japanese. Each rectangle represents a biological function in terms of a Gene Ontology (GO) term, with the size adjusted to represent the P‑value of the GO term in the underlying GO term database. -
The Identification of Proteins That Interact with the N-Terminal Domain of Pitx2c
The identification of proteins that interact with the N-terminal domain of Pitx2c Dora Siontas A thesis submitted to McGill University in partial fulfillment of the requirement of the degree of Master of Science Department of Experimental Medicine McGill University Montreal, Quebec Canada August, 2011 © Dora Siontas Table of Contents Page ABSTRACT……………………………………………………………………..… i RÉSUMÉ………………….…………………………………………………...….. ii ACKNOWLEDGMENTS……………….……………………...…………...…... iii ABBREVIATIONS……………………...……………………………………..… iv LIST OF FIGURES ………………………………………………………..…... viii LIST OF TABLES……………………..……………………………………......... x 1. INTRODUCTION…………………………………………………………….... 1 1.1 Left-right asymmetric patterning……………………………………...…. 1 1.2 The left-right asymmetric molecular cascade………………………..…... 2 1.2.1 The left-right molecular cascade in the chick embryo..……………. 2 1.2.2 The left-right molecular cascade in the mouse embryo……….…… 7 1.3 The Pitx2 gene and protein isoforms………………………………….… 10 1.3.1 Identification of PITX2 as a mutated gene in ARS…………......… 11 1.3.2 Pitx2 function….……………………………..………………........… 11 1.3.3 Pitx2 isoforms…………………………………………..………..….. 13 1.3.4 Expression patterns of the different Pitx2 isoforms………............. 15 1.3.5 Pitx2 is important for asymmetric morphogenesis………………... 17 1.4 The Pitx2c N-terminal domain………………………………………...… 19 1.4.1 The Pitx2c N-terminal domain………………………………..…..… 19 1.4.2 Functional experiments with the Pitx2c N-terminal domain….….. 20 1.4.3 Pitx2-interacting proteins…………….……………………………... 23 2. HYPOTHESIS AND OBJECTIVES……………………………………..….. 25 2.1 Rationale…………………………………………………………………. 25 2.2 Hypothesis…………………………………………………………......… 25 2.3 Objectives……………………………………………………….……….. 26 3. MATERIALS AND METHODS………………………………………….…… 27 3.1 Cloning of the m2cN into pGBKT7………………………………………. 27 3.1.1 Midipreparation of pGBKT7…………………………………...…… 27 3.1.2 RT-PCR of m2cN cDNA…………………………………………..…. 27 3.1.3 Purification and digestion of the m2cN and the pGBKT7 vector…. -
Genome-Wide Screen for Genes Involved in Edna Release During
Genome-wide screen for genes involved in eDNA PNAS PLUS release during biofilm formation by Staphylococcus aureus Alicia S. DeFrancescoa,1, Nadezda Masloboevaa,1, Adnan K. Syeda, Aaron DeLougherya,b, Niels Bradshawa, Gene-Wei Lib, Michael S. Gilmorec,d, Suzanne Walkerd, and Richard Losicka,2 aDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138; bDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142; cDepartment of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA 02114; and dDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115 Edited by Ralph R. Isberg, Howard Hughes Medical Institute, Tufts University School of Medicine, Boston, MA, and approved June 13, 2017 (received for review March 20, 2017) Staphylococcus aureus is a leading cause of both nosocomial and We have shown that the major components of the biofilm community-acquired infection. Biofilm formation at the site of infec- matrix of HG003 are proteins and eDNA, which associate with tion reduces antimicrobial susceptibility and can lead to chronic infec- the biofilm in a manner that depends on a drop in pH during tion. During biofilm formation, a subset of cells liberate cytoplasmic growth in the presence of glucose (5, 6). Many of these proteins proteins and DNA, which are repurposed to form the extracellular are cytoplasmic in origin and are thus moonlighting in their matrix that binds the remaining cells together in large clusters. Using second role as components of the biofilm matrix (5). These a strain that forms robust biofilms in vitro during growth under glu- moonlighting proteins do not depend on eDNA to remain as- cose supplementation, we carried out a genome-wide screen for genes sociated with cells. -
Crystal Structure of the Plexin A3 Intracellular Region Reveals an Autoinhibited Conformation Through Active Site Sequestration
Crystal structure of the plexin A3 intracellular region reveals an autoinhibited conformation through active site sequestration Huawei Hea, Taehong Yangb, Jonathan R. Termana,b, and Xuewu Zhanga,c,1 Departments of aPharmacology, bNeuroscience, and cBiochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9041 Edited by John Kuriyan, University of California, Berkeley, CA, and approved July 27, 2009 (received for review June 22, 2009) Plexin cell surface receptors bind to semaphorin ligands and dendrite morphology (10). The GAP activity is important for plexin transduce signals for regulating neuronal axon guidance. The signaling, and plexin function is lost upon mutation of either of the intracellular region of plexins is essential for signaling and contains two conserved catalytic arginine residues (7–9, 11). a R-Ras/M-Ras GTPase activating protein (GAP) domain that is The GAP domain of plexins is unique in that it is divided into two divided into two segments by a Rho GTPase-binding domain (RBD). segments, referred to as C1 and C2 respectively, by a domain of The regulation mechanisms for plexin remain elusive, although it approximately 200 residues that does not show homology to Ras is known that activation requires both binding of semaphorin to GAPs. The C1 and C2 regions each contain one of the two catalytic the extracellular region and a Rho-family GTPase (Rac1 or Rnd1) to arginine residues (12), and the mechanism through which these two the RBD. Here we report the crystal structure of the plexin A3 arginines are positioned precisely in close proximity for catalysis is intracellular region. The structure shows that the N- and C-terminal not known (13). -
Supplementary File 2A Revised
Supplementary file 2A. Differentially expressed genes in aldosteronomas compared to all other samples, ranked according to statistical significance. Missing values were not allowed in aldosteronomas, but to a maximum of five in the other samples. Acc UGCluster Name Symbol log Fold Change P - Value Adj. P-Value B R99527 Hs.8162 Hypothetical protein MGC39372 MGC39372 2,17 6,3E-09 5,1E-05 10,2 AA398335 Hs.10414 Kelch domain containing 8A KLHDC8A 2,26 1,2E-08 5,1E-05 9,56 AA441933 Hs.519075 Leiomodin 1 (smooth muscle) LMOD1 2,33 1,3E-08 5,1E-05 9,54 AA630120 Hs.78781 Vascular endothelial growth factor B VEGFB 1,24 1,1E-07 2,9E-04 7,59 R07846 Data not found 3,71 1,2E-07 2,9E-04 7,49 W92795 Hs.434386 Hypothetical protein LOC201229 LOC201229 1,55 2,0E-07 4,0E-04 7,03 AA454564 Hs.323396 Family with sequence similarity 54, member B FAM54B 1,25 3,0E-07 5,2E-04 6,65 AA775249 Hs.513633 G protein-coupled receptor 56 GPR56 -1,63 4,3E-07 6,4E-04 6,33 AA012822 Hs.713814 Oxysterol bining protein OSBP 1,35 5,3E-07 7,1E-04 6,14 R45592 Hs.655271 Regulating synaptic membrane exocytosis 2 RIMS2 2,51 5,9E-07 7,1E-04 6,04 AA282936 Hs.240 M-phase phosphoprotein 1 MPHOSPH -1,40 8,1E-07 8,9E-04 5,74 N34945 Hs.234898 Acetyl-Coenzyme A carboxylase beta ACACB 0,87 9,7E-07 9,8E-04 5,58 R07322 Hs.464137 Acyl-Coenzyme A oxidase 1, palmitoyl ACOX1 0,82 1,3E-06 1,2E-03 5,35 R77144 Hs.488835 Transmembrane protein 120A TMEM120A 1,55 1,7E-06 1,4E-03 5,07 H68542 Hs.420009 Transcribed locus 1,07 1,7E-06 1,4E-03 5,06 AA410184 Hs.696454 PBX/knotted 1 homeobox 2 PKNOX2 1,78 2,0E-06 -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase -
(12) Patent Application Publication (10) Pub. No.: US 2017/0198053 A1 Smith Et Al
US 20170 198053A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0198053 A1 Smith et al. (43) Pub. Date: Jul. 13, 2017 (54) USE OF SEMAPHORN-4D BINDING (60) Provisional application No. 62/012,805, filed on Jun. MOLECULES FOR TREATING 16, 2014, provisional application No. 61/979,384, NEURODEGENERATIVE DSORDERS filed on Apr. 14, 2014, provisional application No. 61/893,814, filed on Oct. 21, 2013. (71) Applicant: Vaccinex, Inc., Rochester, NY (US) Publication Classification (72) Inventors: Ernest S. Smith, Ontario, NY (US); Maurice Zauderer, Pittsford, NY (US); (51) Int. C. William J. Bowers, Webster, NY (US); C07K 6/28 (2006.01) Alan Jonason, Pittsford, NY (US) (52) U.S. C. CPC ...... C07K 16/2896 (2013.01); C07K 2317/56 (21) Appl. No.: 15/465,509 (2013.01); A6 IK 2039/505 (2013.01) (22) Filed: Mar. 21, 2017 (57) ABSTRACT Provided herein are methods for alleviating symptoms in a Related U.S. Application Data Subject having a neurodegenerative disorder, comprising (63) Continuation of application No. 15/420,662, filed on administering to the Subject an effective amount of an Jan. 31, 2017. Continuation of application No. isolated binding molecule which specifically binds to Sema 14/519,965, filed on Oct. 21, 2014, now Pat. No. phorin-4D (SEMA4D) or to its Plexin-B1 or Plexin-B2 9,598,495. receptors. Patent Application Publication Jul. 13, 2017. Sheet 1 of 19 US 2017/O198053 A1 apoiopeñenese? p3&###~3de) Patent Application Publication Jul. 13, 2017. Sheet 2 of 19 US 2017/O198053 A1 §§84 æææ???dp?a?º??do.